Steven K Clinton, MD, PHD
Leadership Title: Robert A. and Martha O. Schoenlaub Cancer Research Chair Co-Leader, Molecular Carcinogenesis and Chemoprevention Program
Academic Title: Professor in the College of Food, Agricultural, and Environmental Sciences, College of Education and Human Ecology, College of Medicine
Research Program: Molecular Carcinogenesis and Chemoprevention
About Me
More info forI am a medical oncologist specializing in prostate cancer. I serve as a professor in the Division of Medical Oncology and Department of Urology at The Ohio State University, and hold the Robert A. and Martha O. Schoenlaub Cancer Research Chair. My expertise encompasses the full range of prostate cancer care, from prevention and screening to active surveillance, clinically localized disease and advanced metastatic disease. This effort is the result of seamless interactions among specialized physicians in oncology, urology, pathology and radiation therapy so that our care programs are personalized for each individual. We are very proud to offer a weekly Prostate Cancer Multidisciplinary Clinic where men with a newly diagnosed prostate cancer can receive a comprehensive evaluation and detailed review of treatment options in one afternoon visit. State-of-the-art treatment plans ranging from surgery to radiation therapy to medical oncology, as well as integrated combinations, are offered to ensure the greatest chance of cure and quality survivorship. Our team provides opportunities for men to participate in novel and exciting clinical trials in such areas as nutrition, cancer prevention survivorship and therapeutics, including those involving new combinations of pharmaceuticals and radiation, immune therapeutics and targeted agents. We have established a Prostate Cancer Genetics Clinic to better serve our patients and their families. Rapidly expanding knowledge has clarified a role for inheritance in prostate cancer risk, and we provide an integrated evaluation by certified specialists in genetics counseling. Our evaluation of the family history includes options for genetic analysis to the patient and appropriate family members, such as siblings and descendants (both men and women), as some inherited syndromes relate to risks of cancers other than prostate cancer. In addition to my clinical work, I serve as co-leader of the Molecular Carcinogenesis and Chemoprevention Program at the OSUCCC – James, where my research is dedicated to prostate cancer prevention and therapy, as well as projects focusing on diet, nutrition and lifestyle for cancer prevention and survivorship. My lab team has expertise in molecular biology, cellular and experimental models of carcinogenesis, and human clinical trials. One area of my research emphasizes the impact of dietary patterns, specific foods and nutrients on prostate cancer risk. These studies are often conducted in collaboration with scientists in other disciplines at Ohio State, such as food science and agriculture, in a coordinated "crops to the clinic" research effort. My lab program has published extensively on the role of dietary energy balance and obesity in cancer risk. It also has published studies relating to foods associated with cancer prevention properties, such as hops, tomatoes, soy and cruciferous vegetables, as well as several nutrients, including vitamin D, calcium, omega-3 fatty acids and vitamin E. This work has appeared in such scientific journals as Journal of Nutrition, Molecular Nutrition and Food Research, Clinical Cancer Research, Proceedings of the National Academy of Sciences of the USA, Clinical and Translational Gastroenterology, and Scientific Reports. I am also privileged to serve as co-director of Ohio State’s Foods for Health Discovery Theme, a campus-wide effort in food, nutrition and health, as well as on the World Cancer Research Fund effort to define guidelines for cancer prevention that are employed by many organizations, such as the World Health Organization, to impact healthy food and agriculture policies for nations around the globe.
Clinical Expertise
More info for- Prostate Cancers
- Urogenital Cancers
Research Interests
More info for- Prostatic Neoplasms
- Atherosclerosis
- Neoplasms
- Urinary Bladder Neoplasms
- Breast Neoplasms
- Adenocarcinoma
Where I See Patients
More info forEducation & Training
More info forFellowship - Medical Oncology
- Dana-Farber Cancer Institute
44 Binney St, Boston, MA
Residency - Hematology & Oncology
- University of Chicago Hospitals
5841 S Maryland Ave, Chicago, IL
Medical School
- University of Illinois College of Medicine-Urbana
506 S Mathews Ave, Urbana, IL
- Dana-Farber Cancer Institute
Academic Office & Contact Information
More info forAcademic Office:
Comprehensive Cancer Center
410 W 12th Ave
Columbus, Ohio 43210-1214Phone:
614-293-7525Email:
Steven.Clinton@osumc.eduReviews
More info forPatient Satisfaction Review
The overall patient satisfaction rating is an average of all patient responses to the five questions gathered from the Outpatient Oncology survey, developed by Press Ganey Associates for use in oncology clinics across the country. On behalf of The James, Press Ganey administers the survey to patients who see our providers in an outpatient clinic office. For additional information about the patient satisfaction survey, please visit our
Patient Satisfaction Survey page The comments are submitted by patients and reflect their view and opinions. The comments are not endorsed by and do not necessarily reflect the views of The James.
Publications
More info forOctober 17, 2024Molecular Networking, Docking, and Biological Evaluation of Licarin A from Myristica fragrans as a Potential Cancer Chemopreventive Agent.
Blanco Carcache PJ, Castro-Dionicio IY, Mirtallo Ezzone NP, Salinas-Arrellano ED, Bahar J, Clinton SK, Kinghorn AD
Molecules
October 16, 2024Malnutrition risk screening in adult oncology outpatients: An ASPEN systematic review and clinical recommendations.
Trujillo EB, Kadakia KC, Thomson C, Zhang FF, Livinski A, Pollard K, Mattox T, Tucker A, Williams V, Walsh D, Clinton S, Grossberg A, Jensen G, Levin R, Mills J, Singh A, Smith M, Stubbins R, Wiley K, Sullivan K, Platek M, Spees CK
JPEN J Parenter Enteral Nutr
September 1, 2024Discovery of Natural Products for Cancer Prevention.
Blanco Carcache PJ, Clinton SK, Kinghorn AD
Cancer J
August 21, 2024Bioactive (Poly)phenol Concentrations in Plant-Based Milk Alternatives in the US Market.
Grainger EM, Jiang K, Webb MZ, Kennedy AJ, Chitchumroonchokchai C, Riedl KM, Manubolu M, Clinton SK
J Agric Food Chem
July 23, 2024Bariatric Surgery Is Associated with Lower Concentrations of Fecal Secondary Bile Acids and Their Metabolizing Microbial Enzymes: A Pilot Study.
Hussan H, Ali MR, Lyo V, Webb A, Pietrzak M, Zhu J, Choueiry F, Li H, Cummings BP, Marco ML, Medici V, Clinton SK
Obes Surg
July 4, 2024Coffee, PI3K signaling pathway, and prostate cancer: a prospective study in the Health Professionals Follow-up Study.
Song R, Stopsack KH, Ren J, Mucci LA, Clinton SK, Loda M, Wang M, Giovannucci EL, Wilson KM, Smith-Warner SA
J Acad Nutr Diet
June 8, 2024Patient-Derived Conditionally Reprogrammed Cells in Prostate Cancer Research.
Elbialy A, Kappala D, Desai D, Wang P, Fadiel A, Wang SJ, Makary MS, Lenobel S, Sood A, Gong M, Dason S, Shabsigh A, Clinton S, Parwani AV, Putluri N, Shvets G, Li J, Liu X
Cells
March 7, 2024Author Correction: Optimal dietary patterns for prevention of chronic disease.
Wang P, Song M, Eliassen AH, Wang M, Fung TT, Clinton SK, Rimm EB, Hu FB, Willett WC, Tabung FK, Giovannucci EL
Nat Med
February 13, 2024Targeting metabolic sensing switch GPR84 on macrophages for cancer immunotherapy.
Li J, Ma A, Zhang R, Chen Y, Bolyard C, Zhao B, Wang C, Pich T, Li W, Sun N, Ma Q, Wen H, Clinton SK, Carson WE, Li Z, Xin G
Cancer Immunol Immunother
February 10, 2024Roles of Androgen Receptor Signaling in Urothelial Carcinoma.
Sundi D, Collier KA, Yang Y, Diaz DA, Pohar KS, Singer EA, Gupta S, Carson WE, Clinton SK, Li Z, Messing EM
Cancers (Basel)
January 11, 2024Transcriptomics and Metabolomics Reveal Tomato Consumption Alters Hepatic Xenobiotic Metabolism and Induces Steroidal Alkaloid Metabolite Accumulation in Mice.
Dzakovich MP, Goggans ML, Thomas-Ahner JM, Moran NE, Clinton SK, Francis DM, Cooperstone JL
Mol Nutr Food Res
December 1, 2023Distinctive patterns of sulfide- and butyrate-metabolizing bacteria after bariatric surgery: potential implications for colorectal cancer risk.
Hussan H, Clinton SK, Grainger EM, Webb M, Wang C, Webb A, Needleman B, Noria S, Zhu J, Choueiry F, Pietrzak M, Bailey MT
Gut Microbes
November 29, 2023Historical Obesity and Early-Onset Cancers: A Propensity-Weighted Analysis of the National Health and Nutrition Examination Survey.
Hussan H, Patel A, Ma J, Hinton A, Clinton SK
Dig Dis Sci
October 28, 2023Associations of dietary patterns with kidney cancer risk, kidney cancer-specific mortality and all-cause mortality among postmenopausal women.
Jin Q, Gheeya J, Nepal S, Shi N, Folefac E, Webb MZ, Grainger EM, Wei L, Prosek JM, Focht BC, Gong M, Clinton SK, Tabung FK
Br J Cancer
June 12, 2023Plasma total cholesterol concentration and risk of higher-grade prostate cancer: A nested case-control study and a dose-response meta-analysis.
Liu H, Shui IM, Keum N, Shen X, Wu K, Clinton SK, Cao Y, Song M, Zhang X, Platz EA, Giovannucci EL
Int J Cancer
June 12, 2023Dietary Inflammatory and Insulinemic Potentials, Plasma Metabolome and Risk of Colorectal Cancer.
Lee DH, Jin Q, Shi N, Wang F, Bever AM, Li J, Liang L, Hu FB, Song M, Zeleznik OA, Zhang X, Joshi A, Wu K, Jeon JY, Meyerhardt JA, Chan AT, Eliassen AH, Clish CB, Clinton SK, Giovannucci EL, Tabung FK
Metabolites
May 13, 2023Orchestration of miRNA patterns by testosterone and dietary tomato carotenoids during early prostate carcinogenesis in TRAMP mice.
Wan L, Thomas-Ahner JM, Pearl DK, Erdman JW, Moran NE, Clinton SK
J Nutr
April 1, 2023Nodular Regenerative Hyperplasia of the Liver Associated With Vascular Endothelial Growth Factor Tyrosine Kinase Inhibitor in a Patient With Metastatic Renal Cell Carcinoma.
Rudolph S, Li M, Gheeya J, Zimmerman D, Yin M, Clinton SK, Parwani AV, Yang Y
JCO Precis Oncol
March 14, 2023Hyperinsulinemic and Pro-Inflammatory Dietary Patterns and Metabolomic Profiles Are Associated with Increased Risk of Total and Site-Specific Cancers among Postmenopausal Women.
Jin Q, Shi N, Lee DH, Rexrode KM, Manson JE, Balasubramanian R, Zhang X, Neuhouser ML, Lopez-Pentecost M, Thomson CA, Zick SM, Felix AS, Stover DG, Sardesai SD, Esnakula A, Mo X, Clinton SK, Tabung FK
Cancers (Basel)
March 13, 2023Optimal dietary patterns for prevention of chronic disease.
Wang P, Song M, Eliassen AH, Wang M, Fung TT, Clinton SK, Rimm EB, Hu FB, Willett WC, Tabung FK, Giovannucci EL
Nat Med
January 1, 2023Chemotherapy for the initial treatment of metastatic prostate adenocarcinoma and neuroendocrine carcinoma at diagnosis: real world application and impact in the SEER database (2004 -2018).
Wang S, Yin M, Wang P, Folefac E, Monk JP, Tabung FK, Clinton SK
Front Oncol
January 1, 2023A multicenter study assessing survival in patients with metastatic renal cell carcinoma receiving immune checkpoint inhibitor therapy with and without cytoreductive nephrectomy.
Gross EE, Li M, Yin M, Orcutt D, Hussey D, Trott E, Holt SK, Dwyer ER, Kramer J, Oliva K, Gore JL, Schade GR, Lin DW, Tykodi SS, Hall ET, Thompson JA, Parikh A, Yang Y, Collier KA, Miah A, Mori-Vogt S, Hinkley M, Mortazavi A, Monk P, Folefac E, Clinton SK, Psutka SP
Urol Oncol
November 10, 2022Application of the Updated WCRF/AICR Cancer Prevention Score as an Outcome for Cancer Survivors Participating in a Tailored and Intensive Dietary and Physical Activity Intervention.
Hill EB, Grainger EM, Young GS, Clinton SK, Spees CK
Nutrients
November 1, 2022Physical Activity and Health-Related Quality of Life in Women With Breast Cancer: A Meta-Analysis.
Aune D, Markozannes G, Abar L, Balducci K, Cariolou M, Nanu N, Vieira R, Anifowoshe YO, Greenwood DC, Clinton SK, Giovannucci EL, Gunter MJ, Jackson A, Kampman E, Lund V, McTiernan A, Riboli E, Allen K, Brockton NT, Croker H, Katsikioti D, McGinley-Gieser D, Mitrou P, Wiseman M, Velikova G, Demark-Wahnefried W, Norat T, Tsilidis KK, Chan DSM
JNCI Cancer Spectr
October 24, 2022Postdiagnosis body fatness, weight change and breast cancer prognosis: Global Cancer Update Program (CUP global) systematic literature review and meta-analysis.
Chan DSM, Vieira R, Abar L, Aune D, Balducci K, Cariolou M, Greenwood DC, Markozannes G, Nanu N, Becerra-Tomás N, Giovannucci EL, Gunter MJ, Jackson AA, Kampman E, Lund V, Allen K, Brockton NT, Croker H, Katsikioti D, McGinley-Gieser D, Mitrou P, Wiseman M, Cross AJ, Riboli E, Clinton SK, McTiernan A, Norat T, Tsilidis KK
Int J Cancer
October 24, 2022Postdiagnosis body fatness, recreational physical activity, dietary factors and breast cancer prognosis: Global Cancer Update Programme (CUP Global) summary of evidence grading.
Tsilidis KK, Cariolou M, Becerra-Tomás N, Balducci K, Vieira R, Abar L, Aune D, Markozannes G, Nanu N, Greenwood DC, Giovannucci EL, Gunter MJ, Jackson AA, Kampman E, Lund V, Allen K, Brockton NT, Croker H, Katsikioti D, McGinley-Gieser D, Mitrou P, Wiseman M, Cross AJ, Riboli E, Clinton SK, McTiernan A, Norat T, Chan DSM
Int J Cancer
October 24, 2022Postdiagnosis dietary factors, supplement use and breast cancer prognosis: Global Cancer Update Programme (CUP Global) systematic literature review and meta-analysis.
Becerra-Tomás N, Balducci K, Abar L, Aune D, Cariolou M, Greenwood DC, Markozannes G, Nanu N, Vieira R, Giovannucci EL, Gunter MJ, Jackson AA, Kampman E, Lund V, Allen K, Brockton NT, Croker H, Katsikioti D, McGinley-Gieser D, Mitrou P, Wiseman M, Cross AJ, Riboli E, Clinton SK, McTiernan A, Norat T, Tsilidis KK, Chan DSM
Int J Cancer
October 24, 2022Postdiagnosis recreational physical activity and breast cancer prognosis: Global Cancer Update Programme (CUP Global) systematic literature review and meta-analysis.
Cariolou M, Abar L, Aune D, Balducci K, Becerra-Tomás N, Greenwood DC, Markozannes G, Nanu N, Vieira R, Giovannucci EL, Gunter MJ, Jackson AA, Kampman E, Lund V, Allen K, Brockton NT, Croker H, Katsikioti D, McGinley-Gieser D, Mitrou P, Wiseman M, Cross AJ, Riboli E, Clinton SK, McTiernan A, Norat T, Tsilidis KK, Chan DSM
Int J Cancer
September 2, 2022Research gaps and opportunities in precision nutrition: an NIH workshop report.
Lee BY, Ordovás JM, Parks EJ, Anderson CAM, Barabási AL, Clinton SK, de la Haye K, Duffy VB, Franks PW, Ginexi EM, Hammond KJ, Hanlon EC, Hittle M, Ho E, Horn AL, Isaacson RS, Mabry PL, Malone S, Martin CK, Mattei J, Meydani SN, Nelson LM, Neuhouser ML, Parent B, Pronk NP, Roche HM, Saria S, Scheer FAJL, Segal E, Sevick MA, Spector TD, Van Horn LB, Varady KA, Voruganti VS, Martinez MF
Am J Clin Nutr
June 22, 2022Colorectal Cancer Risk Is Impacted by Sex and Type of Surgery After Bariatric Surgery.
Hussan H, Akinyeye S, Mihaylova M, McLaughlin E, Chiang C, Clinton SK, Lieberman D
Obes Surg
May 16, 2022Exercise, Diet, and Weight Management During Cancer Treatment: ASCO Guideline.
Ligibel JA, Bohlke K, May AM, Clinton SK, Demark-Wahnefried W, Gilchrist SC, Irwin ML, Late M, Mansfield S, Marshall TF, Meyerhardt JA, Thomson CA, Wood WA, Alfano CM
J Clin Oncol
April 8, 2022Phosphorylated MED1 links transcription recycling and cancer growth.
Chen Z, Ye Z, Soccio RE, Nakadai T, Hankey W, Zhao Y, Huang F, Yuan F, Wang H, Cui Z, Sunkel B, Wu D, Dzeng RK, Thomas-Ahner JM, Huang THM, Clinton SK, Huang J, Lazar MA, Jin VX, Roeder RG, Wang Q
Nucleic Acids Res
April 1, 2022β-Carotene Oxygenase 2 Genotype Modulates the Impact of Dietary Lycopene on Gene Expression during Early TRAMP Prostate Carcinogenesis.
Moran NE, Thomas-Ahner JM, Smith JW, Silva C, Hason NA, Erdman JW, Clinton SK
J Nutr
March 15, 2022In Vitro Imaging of Lycopene Delivery to Prostate Cancer Cells.
Scarpitti BT, Chitchumroonchokchai C, Clinton SK, Schultz ZD
Anal Chem
March 12, 2022Tomatoes, Lycopene, and Prostate Cancer: What Have We Learned from Experimental Models?
Moran NE, Thomas-Ahner JM, Wan L, Zuniga KE, Erdman JW, Clinton SK
J Nutr
January 13, 2022Longitudinal trajectories of lifetime body shape and prostate cancer angiogenesis.
Wang QL, Song M, Clinton SK, Mucci LA, Lagergren J, Giovannucci EL
Eur J Epidemiol
January 1, 2022Social cognitive outcomes are associated with improvements in mobility performance following lifestyle intervention in prostate cancer patients undergoing androgen deprivation therapy.
Chaplow ZL, Lucas AR, Grainger E, Simpson C, Fairman CM, DeScenza VR, Bowman J, Clinton SK, Focht BC
PLoS One
January 1, 2022Utility of machine learning in developing a predictive model for early-age-onset colorectal neoplasia using electronic health records.
Hussan H, Zhao J, Badu-Tawiah AK, Stanich P, Tabung F, Gray D, Ma Q, Kalady M, Clinton SK
PLoS One
December 29, 2021β-carotene Oxygenase 2 Genotype Modulates the Impact of Dietary Lycopene On Gene Expression During Early TRAMP Prostate Carcinogenesis.
Moran NE, Thomas-Ahner JM, Smith JW, Silva C, Hason NA, Erdman JW, Clinton SK
J Nutr
October 9, 2021Aspirin use and prostate tumor angiogenesis.
Fu BC, Wang K, Mucci LA, Clinton SK, Giovannucci EL
Cancer Causes Control
August 16, 2021Dietary Omega-3 Fatty Acid Intake Impacts Peripheral Blood DNA Methylation -Anti-inflammatory Effects and Individual Variability in a Pilot Study.
Frankhouser DE, Steck S, Sovic MG, Belury MA, Wang Q, Clinton SK, Bundschuh R, Yan PS, Yee LD
J Nutr Biochem
April 7, 2021Dietary Patterns of Insulinemia, Inflammation and Glycemia and Pancreatic Cancer Risk: Findings from the Women's Health Initiative.
Jin Q, Hart PA, Shi N, Joseph JJ, Donneyong M, Conwell DL, Clinton SK, Cruz-Monserrate Z, Brasky TM, Tinker LF, Liu S, Shadyab AH, Thomson CA, Qi L, Rohan TE, Tabung FK
Cancer Epidemiol Biomarkers Prev
March 17, 2021Considerations for Use of the Phenol-Explorer Database to Estimate Dietary (Poly)phenol Intake.
Hill EB, Kennedy AJ, Roberts KM, Riedl KM, Grainger EM, Clinton SK
J Acad Nutr Diet
February 11, 2021Inhibition of androgen/AR signaling inhibits diethylnitrosamine (DEN) induced tumour initiation and remodels liver immune cell networks.
Helms TH, Mullins RD, Thomas-Ahner JM, Kulp SK, Campbell MJ, Lucas F, Schmidt N, LeMoine DM, Getaneh S, Xie Z, Phelps MA, Clinton SK, Coss CC
Sci Rep
January 6, 2021Risk Factors for Emergency Room and Hospital Care Among Patients With Solid Tumors on Immune Checkpoint Inhibitor Therapy.
Parikh AB, Zhong X, Mellgard G, Qin Q, Patel VG, Wang B, Alerasool P, Garcia P, Leiter A, Gallagher EJ, Clinton S, Mortazavi A, Monk P, Folefac E, Yin M, Yang Y, Galsky M, Oh WK, Tsao CK
Am J Clin Oncol
January 6, 2021Insulinemic and Inflammatory Dietary Patterns and Risk of Prostate Cancer.
Fu BC, Tabung FK, Pernar CH, Wang W, Gonzalez-Feliciano AG, Chowdhury-Paulino IM, Clinton SK, Folefac E, Song M, Kibel AS, Giovannucci EL, Mucci LA
Eur Urol
January 1, 2021Proinflammatory and Hyperinsulinemic Dietary Patterns Are Associated With Specific Profiles of Biomarkers Predictive of Chronic Inflammation, Glucose-Insulin Dysregulation, and Dyslipidemia in Postmenopausal Women.
Shi N, Aroke D, Jin Q, Lee DH, Hussan H, Zhang X, Manson JE, LeBlanc ES, Barac A, Arcan C, Clinton SK, Giovannucci EL, Tabung FK
Front Nutr
November 20, 2020Increased bleeding risk associated with concurrent vascular endothelial growth factor receptor tyrosine kinase inhibitors and low-molecular-weight heparin.
Patel SH, George TL, Wang TF, Vogt SM, Folefac E, Xu M, Yang Y, Parikh AB, Verschraegen CF, Clinton SK, Yin M
Cancer
October 23, 2020Alterations of DNA damage response genes correlate with response and overall survival in anti-PD-1/PD-L1-treated advanced urothelial cancer.
Joshi M, Grivas P, Mortazavi A, Monk P, Clinton SK, Sue-Ann Woo M, Holder SL, Drabick JJ, Yin M
Cancer Med
August 27, 2020Post-diagnosis dietary insulinemic potential and survival outcomes among colorectal cancer patients.
Tabung FK, Noonan A, Lee DH, Song M, Clinton SK, Spakowicz D, Wu K, Cheng E, Meyerhardt JA, Fuchs CS, Giovannucci EL
BMC Cancer
July 12, 2020Inflammatory and Insulinemic Dietary Patterns: Influence on Circulating Biomarkers and Prostate Cancer Risk.
Aroke D, Folefac E, Shi N, Jin Q, Clinton SK, Tabung FK
Cancer Prev Res (Phila)
May 23, 2020Prostate Cancer Cell Phenotypes Remain Stable Following PDE5 Inhibition in the Clinically Relevant Range.
Hankey W, Sunkel B, Yuan F, He H, Thomas-Ahner JM, Chen Z, Clinton SK, Huang J, Wang Q
Transl Oncol
May 5, 2020Dietary Tomato or Lycopene Do Not Reduce Castration-Resistant Prostate Cancer Progression in a Murine Model.
Rowles JL, Smith JW, Applegate CC, Miller RJ, Wallig MA, Kaur A, Sarol JN, Musaad S, Clinton SK, O'Brien WD, Erdman JW
J Nutr
April 10, 2020Prognostic Value of DNA Damage Response Genomic Alterations in Relapsed/Advanced Urothelial Cancer.
Yin M, Grivas P, Wang QE, Mortazavi A, Emamekhoo H, Holder SL, Drabick JJ, Woo SA, Pal S, Vasekar M, Folefac E, Clinton S, Monk P, Joshi M
Oncologist
April 1, 2020Not So Fast: Deintensification Therapy for Locally Advanced Oral Cavity Cancer.
Mitchell DL, Clinton SK, Old MO
Int J Radiat Oncol Biol Phys
April 1, 2020Rising Incidence of Colorectal Cancer in Young Adults Corresponds With Increasing Surgical Resections in Obese Patients.
Hussan H, Patel A, Le Roux M, Cruz-Monserrate Z, Porter K, Clinton SK, Carethers JM, Courneya KS
Clin Transl Gastroenterol
April 1, 2020Effects of a lifestyle intervention on body composition in prostate cancer patients on androgen deprivation therapy.
Chaplow ZL, Focht BC, Lucas AR, Grainger E, Simpson C, Buell J, Fairman CM, Thomas-Ahner JM, Bowman J, DeScenza VR, Monk JP, Mortazavi A, Clinton SK
JCSM Clin Rep
March 27, 2020Wee1 Kinase Inhibitor AZD1775 Effectively Sensitizes Esophageal Cancer to Radiotherapy.
Yang L, Shen C, Pettit CJ, Li T, Hu AJ, Miller ED, Zhang J, Lin SH, Williams TM
Clin Cancer Res
Consulting and Related Relationships
More info forAt The Ohio State University Wexner Medical Center, we support a faculty member’s research and consulting in collaboration with medical device, research and/or drug companies because a faculty member’s expertise can guide important advancements in the practice of medicine and improve patient care. In order to provide effective management of these relationships, the university requires annual disclosures from all faculty members with external interests related to their university responsibilities. As of 09/30/2024, Dr. Clinton has reported no relationships with companies or entities.
Patient Comments
I'm very happy and thankful for the care I receive from Dr.Clinton and staff
Dr. Clinton is the best. Please don't let him retire.
We were treated like old friends of value
I have been seeeing Dr. Clinton for 15 years, and his knowledge, communication skills, and overall professionalism is excellent. I can not imagine a better health care provider than Dr. Clinton. Thanks you, Dr. Clinton.
I have complete trust in Dr. Clinton and the entire staff.
Dr. Clinton and all of his clinical staff are just the best.
I mean, when you're dealing with the best, what's to say. Who am I to judge ?I'm grateful to be alive and on the getting better side of things.
Dr. Clinton Excellent doctor.
Dr. Clinton and staff are the best! They treat you like family.
10/10
Very pleased with Dr. Clinton and his staff
Dr. Clinton & Andrea are the BEST!!
Nursing staff is incredible
Dr. Clinton and his team are outstanding care providers. I feel very fortunate to have them as my oncology team
Dr. Clinton and his staff are outstanding! They are the best! Period!
Dr. Clinton and his staff (nurse practitioners, nurses, and MAs are all the best!
Dr. Clinton and his teams care is the best I have ever experienced.
I am extremely grateful for the excellent care and medical treatment plan given by Dr. Steven Clinton.
Great people
Dr Clinton is a superb oncologist and very thorough in his work with patients. Heads up an excellent team.
Always take the time to talk to you
Dr. Clinton is terrific
Dr. Clinton and his staff are all wonderful. We feel very blessed to have him as our cancer specialist. He is very knowledgable and informative, easy to talk to and just a great doctor in every respect.
Doctor Clinton is the best!
Dr. Clinton and his team have become good friends over the last 14 years. They are all professional while also being very friendly.
Dr Clinton and staff are top notch
The treatments have kept me going for12 and a half years. Therefore no complaints.
Excellent staff and physician
Dr. Clinton and his staff provide excellent care. They are top notch at each appointment, in fully addressing any questions and concerns I have. Capable and professional.
Dr Clinton is an exceptional physician who always takes the time to answer my questions. He treats me with respect and empathy. As does his staff. I consider myself to be quite lucky to have this physician as my oncologist. I know I am in very good hands.
They seem to forget to go over lab results most visits unless I ask ! They just say it looks good,but I want to know and understand the results!!
With Clinton, the process is a well-oiled machine. Excellent!
Love the doctors, staff and new facility.
Care provider is excellent
Very good
Excellent care since 2006. Dr Clinton and his team have treated my metastatic PC with great skill and excellent results. Greatly appreciated
Great Doctor
This is a six-month visit, the care provider discussed any issues I had with the test results which were very satisfactory.
Dr. Clinton has been providing me with oncology related services since 2010, and I find him to be extremely helpful in monitoring and managing my post cancer surgery treatment. I am a big fan of Dr. Clinton.
Overall top quality professionals
Love my doctors
I believe that I am receiving excellent care from Dr. Clinton and his staff. And I believe that theySincerely care about me and that they are subject matter experts. His nursing staff is exceptionally kind and friendly. I have reviewed Dr. Clinton's treatment notes and they clearly evidence his professionalism, dedication, and competence. I know I am in excellent hands and I am very grateful.
Dr. Clinton is the best and most comprehensive provider I have ever had in my 77 years. He has great knowledge and I have great confidence in him.
The best team in the dept.
Dr. Clinton is awesome!
Dr. Clinton is an exceptional care provider.
Dr Clinton and staff care and provide the care you rarely get anymore.